AI Science Tracker
EN

Extreme phenotype-derived machine learning reveals susceptibility and resilience signatures for severe diabetic retinopathy.

Beijing Diabetes Institute; Beijing Tongren Hospital; Capital Medical University · 27 Aug 2026 · medicine

Discovery

Extreme phenotype-derived machine learning reveals susceptibility and resilience signatures for severe diabetic retinopathy.

Source check: Source checked. Not independent scientific confirmation.

Finding: Original Results/Discussion examined; the case-specific finding and its limits are summarized. Original Methods examined; model operation and its relationship to the stated result are described in the source. Testing: Original Methods/Results identify the datasets, assays or cohort comparison supporting the claim.. Extreme-phenotype ML separates susceptibility/resilience signatures for severe diabetic retinopathy, with internal validation AUC 0.90 and feature importance from clinical variables. This is a specific clinical cohort risk-stratification result, not causal biology or prospective prediction. Source affiliation was not stated in the reviewed case checks and was unavailable in the local bibliographic cache.

Technology: Original Methods examined; model operation and its relationship to the stated result are described in the source.

Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.

AI contribution
Original Methods examined; model operation and its relationship to the stated result are described in the source.
Test and result
Original Methods/Results identify the datasets, assays or cohort comparison supporting the claim.
Limitation / still unknown
Extreme-phenotype ML separates susceptibility/resilience signatures for severe diabetic retinopathy, with internal validation AUC 0.90 and feature importance from clinical variables. This is a specific clinical cohort risk-stratification result, not causal biology or prospective prediction.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/fendo/articles/10.3389/fendo.2026.1933878/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 4/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.